{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:20:37Z","timestamp":1792200037738,"version":"4.4.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R00AG065645"],"award-info":[{"award-number":["R00AG065645"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM149497"],"award-info":[{"award-number":["GM149497"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41380-025-03095-w","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T09:12:52Z","timestamp":1751101972000},"page":"5121-5136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-122X","authenticated-orcid":false,"given":"Subodh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-7944","authenticated-orcid":false,"given":"Enrique","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1398-9943","authenticated-orcid":false,"given":"Daniela","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-5815","authenticated-orcid":false,"given":"Bhupender","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-9907","authenticated-orcid":false,"given":"Davin","family":"Devara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-5472","authenticated-orcid":false,"given":"Shrikanth S.","family":"Gadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"3095_CR1","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19:1598-695. https:\/\/doi.org\/10.1002\/alz.13016.","DOI":"10.1002\/alz.13016"},{"key":"3095_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5114\/fn.2019.85929","volume":"57","author":"RA Armstrong","year":"2019","unstructured":"Armstrong RA. Risk factors for Alzheimer\u2019s disease. Folia Neuropathol. 2019;57:87\u2013105. https:\/\/doi.org\/10.5114\/fn.2019.85929.","journal-title":"Folia Neuropathol"},{"key":"3095_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s Disease. Curr Neuropharmacol. 2020;18:1106\u201325. https:\/\/doi.org\/10.2174\/1570159X18666200528142429.","journal-title":"Curr Neuropharmacol"},{"key":"3095_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fnins.2019.00735","volume":"13","author":"J Jackson","year":"2019","unstructured":"Jackson J, Jambrina E, Li J, Marston H, Menzies F, Phillips K, et al. Targeting the synapse in Alzheimer\u2019s disease. Front Neurosci. 2019;13:735 https:\/\/doi.org\/10.3389\/fnins.2019.00735.","journal-title":"Front Neurosci."},{"key":"3095_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41525-022-00319-8","volume":"7","author":"S Kumar","year":"2022","unstructured":"Kumar S, Orlov E, Gowda P, Bose C, Swerdlow RH, Lahiri DK, et al. Synaptosome microRNAs regulate synapse functions in Alzheimer\u2019s disease. NPJ Genom Med. 2022;7:47 https:\/\/doi.org\/10.1038\/s41525-022-00319-8.","journal-title":"NPJ Genom Med."},{"key":"3095_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/B978-0-12-819410-2.00022-9","volume":"184","author":"S Pelucchi","year":"2022","unstructured":"Pelucchi S, Gardoni F, Di Luca M, Marcello E. Synaptic dysfunction in early phases of Alzheimer\u2019s Disease. Handb Clin Neurol. 2022;184:417\u201338. https:\/\/doi.org\/10.1016\/B978-0-12-819410-2.00022-9.","journal-title":"Handb Clin Neurol"},{"key":"3095_CR7","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah S, Gan J. Alzheimer\u2019s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression. Front Synaptic Neurosci. 2023;15:1129036 https:\/\/doi.org\/10.3389\/fnsyn.2023.1129036.","journal-title":"Front Synaptic Neurosci."},{"key":"3095_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10:45 https:\/\/doi.org\/10.1186\/s40035-021-00270-1.","journal-title":"Transl Neurodegener."},{"key":"3095_CR9","doi-asserted-by":"publisher","first-page":"e202103052","DOI":"10.1083\/jcb.202103052","volume":"220","author":"TC S\u00fcdhof","year":"2021","unstructured":"S\u00fcdhof TC. The cell biology of synapse formation. J Cell Biol. 2021;220:e202103052 https:\/\/doi.org\/10.1083\/jcb.202103052.","journal-title":"J Cell Biol"},{"key":"3095_CR10","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA. 1998;95:6448\u201353. https:\/\/doi.org\/10.1073\/pnas.95.11.6448.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3095_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4103\/1673-5374.230276","volume":"13","author":"J Marsh","year":"2018","unstructured":"Marsh J, Alifragis P. Synaptic dysfunction in Alzheimer\u2019s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regen Res. 2018;13:616\u201323. https:\/\/doi.org\/10.4103\/1673-5374.230276.","journal-title":"Neural Regen Res."},{"key":"3095_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/caff.2019.0013","volume":"9","author":"M Temido-Ferreira","year":"2019","unstructured":"Temido-Ferreira M, Coelho JE, Pousinha PA, Lopes LV. Novel players in the aging synapse: Impact on cognition. J Caffeine Adenosine Res. 2019;9:104\u201327. https:\/\/doi.org\/10.1089\/caff.2019.0013.","journal-title":"J Caffeine Adenosine Res."},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2022.07.011","volume":"139","author":"WY Fu","year":"2023","unstructured":"Fu WY, Ip NY. The role of genetic risk factors of Alzheimer\u2019s disease in synaptic dysfunction. Semin Cell Dev Biol. 2023;139:3\u201312. https:\/\/doi.org\/10.1016\/j.semcdb.2022.07.011.","journal-title":"Semin Cell Dev Biol"},{"key":"3095_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4020-5943-8_6","volume":"43","author":"F Bai","year":"2007","unstructured":"Bai F, Witzmann FA. Synaptosome proteomics. Subcell Biochem. 2007;43:77\u201398. https:\/\/doi.org\/10.1007\/978-1-4020-5943-8_6.","journal-title":"Subcell Biochem"},{"key":"3095_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4103\/1673-5374.360172","volume":"18","author":"S Kumar","year":"2023","unstructured":"Kumar S. Synaptosome microRNAs: emerging synapse players in aging and Alzheimer\u2019s disease. Neural Regen Res. 2023;18:1275\u20136. https:\/\/doi.org\/10.4103\/1673-5374.360172.","journal-title":"Neural Regen Res"},{"key":"3095_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/encyclopedia3020027","volume":"3","author":"H Trebesova","year":"2023","unstructured":"Trebesova H, Grilli M. Synaptosomes: A functional tool for studying neuroinflammation. encyclopedia. 2023;3:406\u201318. https:\/\/doi.org\/10.3390\/encyclopedia3020027.","journal-title":"encyclopedia"},{"key":"3095_CR17","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","volume":"26","author":"N Chopra","year":"2021","unstructured":"Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, et al. MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry. 2021;26:5636\u201357. https:\/\/doi.org\/10.1038\/s41380-019-0610-2.","journal-title":"Mol Psychiatry"},{"key":"3095_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41380-021-01351-3","volume":"27","author":"R Wang","year":"2022","unstructured":"Wang R, Chopra N, Nho K, Maloney B, Obukhov AG, Nelson PT, et al. Human microRNA (miR-20b-5p) modulates Alzheimer\u2019s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer\u2019s biomarkers. Mol Psychiatry. 2022;27:1256\u201373. https:\/\/doi.org\/10.1038\/s41380-021-01351-3.","journal-title":"Mol Psychiatry"},{"key":"3095_CR19","doi-asserted-by":"publisher","first-page":"165937","DOI":"10.1016\/j.bbadis.2020.165937","volume":"1866","author":"S Kumar","year":"2020","unstructured":"Kumar S, Reddy PH. The role of synaptic microRNAs in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165937 https:\/\/doi.org\/10.1016\/j.bbadis.2020.165937.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3095_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/cells10010113","volume":"10","author":"D Siedlecki-Wullich","year":"2021","unstructured":"Siedlecki-Wullich D, Mi\u00f1ano-Molina AJ, Rodr\u00edguez-\u00c1lvarez J. MicroRNAs as early biomarkers of Alzheimer\u2019s disease: a synaptic perspective. Cells. 2021;10:113 https:\/\/doi.org\/10.3390\/cells10010113.","journal-title":"Cells"},{"key":"3095_CR21","doi-asserted-by":"publisher","first-page":"743573","DOI":"10.3389\/fnagi.2021.743573","volume":"13","author":"NZ Abuelezz","year":"2021","unstructured":"Abuelezz NZ, Nasr FE, AbdulKader MA, Bassiouny AR, Zaky A. MicroRNAs as potential orchestrators of Alzheimer\u2019s disease-related pathologies: insights on current status and future possibilities. Front Aging Neurosci. 2021;13:743573 https:\/\/doi.org\/10.3389\/fnagi.2021.743573.","journal-title":"Front Aging Neurosci."},{"key":"3095_CR22","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.arr.2024.102377","volume":"99","author":"S Dalal","year":"2024","unstructured":"Dalal S, Ramirez-Gomez J, Sharma B, Devara D, Kumar S. MicroRNAs and synapse turnover in Alzheimer\u2019s disease. Ageing Res Rev. 2024;99:102377 https:\/\/doi.org\/10.1016\/j.arr.2024.102377.","journal-title":"Ageing Res Rev"},{"key":"3095_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"SS H\u00e9bert","year":"2009","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L, Bergmans B, Papadopoulou AS, Delacourte A, et al. MicroRNA regulation of Alzheimer\u2019s amyloid precursor protein expression. Neurobiol Dis. 2009;33:422\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2008.11.009.","journal-title":"Neurobiol Dis"},{"key":"3095_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuron.2010.01.005","volume":"65","author":"D Edbauer","year":"2010","unstructured":"Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 [published correction appears in Neuron. 2010 Oct 6;68(1):161]. Neuron. 2010;65:373\u201384. https:\/\/doi.org\/10.1016\/j.neuron.2010.01.005.","journal-title":"Neuron"},{"key":"3095_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nn.3762","volume":"17","author":"M Letellier","year":"2014","unstructured":"Letellier M, Elramah S, Mondin M, Soula A, Penn A, Choquet D, et al. MiR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling [published correction appears in Nat Neurosci. 2014 Dec;17(12):1841]. Nat Neurosci. 2014;17:1040\u20132. https:\/\/doi.org\/10.1038\/nn.3762.","journal-title":"Nat Neurosci"},{"key":"3095_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","volume":"1862","author":"S Kumar","year":"2016","unstructured":"Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease? Biochim Biophys Acta. 2016;1862:1617\u201327. https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.001.","journal-title":"Biochim Biophys Acta"},{"key":"3095_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","volume":"146","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Bhatti JS, Reddy PH. MicroRNAs as peripheral biomarkers in aging and age-related diseases. Prog Mol Biol Transl Sci. 2017;146:47\u201394. https:\/\/doi.org\/10.1016\/bs.pmbts.2016.12.013.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3095_CR28","doi-asserted-by":"publisher","first-page":"585432","DOI":"10.3389\/fnins.2020.585432","volume":"14","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Jaber V, Alexandrov PN, Vergallo A, Lista S, Hampel H, et al. MicroRNA-based biomarkers in Alzheimer\u2019s disease (AD). Front Neurosci. 2020;14:585432 https:\/\/doi.org\/10.3389\/fnins.2020.585432.","journal-title":"Front Neurosci."},{"key":"3095_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ncrna7010008","volume":"7","author":"C Kanach","year":"2021","unstructured":"Kanach C, Blusztajn JK, Fischer A, Delalle I. MicroRNAs as candidate biomarkers for Alzheimer\u2019s disease. Noncoding RNA. 2021;7:8 https:\/\/doi.org\/10.3390\/ncrna7010008.","journal-title":"Noncoding RNA"},{"key":"3095_CR30","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.1016\/j.biopha.2022.112681","volume":"148","author":"S Liu","year":"2022","unstructured":"Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, et al. MicroRNAs in Alzheimer\u2019s disease: potential diagnostic markers and therapeutic targets. Biomed Pharmacother. 2022;148:112681 https:\/\/doi.org\/10.1016\/j.biopha.2022.112681.","journal-title":"Biomed Pharmacother"},{"key":"3095_CR31","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/j.bbih.2021.100227","volume":"13","author":"QS Li","year":"2021","unstructured":"Li QS, De Muynck L. Differentially expressed genes in Alzheimer\u2019s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. Brain Behav Immun Health. 2021;13:100227 https:\/\/doi.org\/10.1016\/j.bbih.2021.100227.","journal-title":"Brain Behav Immun Health"},{"key":"3095_CR32","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.3892\/mmr.2015.4271","volume":"12","author":"W Hu","year":"2015","unstructured":"Hu W, Lin X, Chen K. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer\u2019s disease. Mol Med Rep. 2015;12:6679\u201387. https:\/\/doi.org\/10.3892\/mmr.2015.4271.","journal-title":"Mol Med Rep"},{"key":"3095_CR33","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.3390\/molecules26175113","volume":"26","author":"A Rybak-Wolf","year":"2021","unstructured":"Rybak-Wolf A, Plass M. RNA dynamics in Alzheimer\u2019s disease. Molecules. 2021;26:5113 https:\/\/doi.org\/10.3390\/molecules26175113.","journal-title":"Molecules"},{"key":"3095_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","volume":"18","author":"A Lle\u00f3","year":"2019","unstructured":"Lle\u00f3 A, N\u00fa\u00f1ez-Llaves R, Alcolea D, Chiva C, Balateu-Pa\u00f1os D, Colom-Cadena M, et al. Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid. Mol Cell Proteomics. 2019;18:546\u201360. https:\/\/doi.org\/10.1074\/mcp.RA118.001290.","journal-title":"Mol Cell Proteomics"},{"key":"3095_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnagi.2018.00041","volume":"10","author":"S Kumar","year":"2018","unstructured":"Kumar S, Reddy PH. MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update. Front Aging Neurosci. 2018;10:41 https:\/\/doi.org\/10.3389\/fnagi.2018.00041.","journal-title":"Front Aging Neurosci"},{"key":"3095_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nature Methods. 2015;12:357\u201360. https:\/\/doi.org\/10.1038\/nmeth.3317.","journal-title":"Nature Methods"},{"key":"3095_CR37","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. 1000 Genome project data processing subgroup. The sequence slignment\/map format and SAMtools. Bioinformatics. 2009;25:2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics."},{"key":"3095_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","journal-title":"Bioinformatics"},{"key":"3095_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550 https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"3095_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc"},{"key":"3095_CR41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology. 2008;26:1367\u201372. https:\/\/doi.org\/10.1038\/nbt.1511.","journal-title":"Nature Biotechnology"},{"key":"3095_CR42","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nature Protocols. 2016;11:2301\u201319. https:\/\/doi.org\/10.1038\/nprot.2016.136.","journal-title":"Nature Protocols"},{"key":"3095_CR43","doi-asserted-by":"publisher","unstructured":"Gierlinski M, Gastaldello F, Cole C, Barton GJ Proteus: An R package for downstream analysis of MaxQuant output. bioRxiv. [Preprint] 2018, https:\/\/doi.org\/10.1101\/416511.","DOI":"10.1101\/416511"},{"key":"3095_CR44","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.4103\/NRR.NRR-D-23-01064","volume":"19","author":"B Sharma","year":"2024","unstructured":"Sharma B, Torres MM, Rodriguez S, Gangwani L, Kumar S. MicroRNA-502-3p regulates GABAergic synapse function in hippocampal neurons. Neural Regen Res. 2024;19:2698\u2013707. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01064.","journal-title":"Neural Regen Res"},{"key":"3095_CR45","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","volume":"35","author":"A Singh","year":"2019","unstructured":"Singh A, Shannon CP, Gautier B, Rohart F, Vacher M, Tebbutt SJ, et al. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics. 2019;35:3055\u201362. https:\/\/doi.org\/10.1093\/bioinformatics\/bty1054.","journal-title":"Bioinformatics"},{"key":"3095_CR46","doi-asserted-by":"publisher","first-page":"102123","DOI":"10.1016\/j.arr.2023.102123","volume":"92","author":"J Rivera","year":"2023","unstructured":"Rivera J, Sharma B, Torres MM, Kumar S. Factors affecting the GABAergic synapse function in Alzheimer\u2019s disease: Focus on microRNAs. Ageing Res Rev. 2023;92:102123 https:\/\/doi.org\/10.1016\/j.arr.2023.102123.","journal-title":"Ageing Res Rev"},{"key":"3095_CR47","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(16)00065-X","volume":"15","author":"B Maloney","year":"2016","unstructured":"Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 2016;15:760\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(16)00065-X.","journal-title":"Lancet Neurol"},{"key":"3095_CR48","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/mp.2009.82","volume":"14","author":"DK Lahiri","year":"2009","unstructured":"Lahiri DK, Maloney B, Zawia NH. The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry. 2009;14:992\u20131003. https:\/\/doi.org\/10.1038\/mp.2009.82.","journal-title":"Mol Psychiatry"},{"key":"3095_CR49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nature Genetics. 2019;51:414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nature Genetics"},{"key":"3095_CR50","doi-asserted-by":"publisher","first-page":"104617","DOI":"10.1016\/j.nbd.2019.104617","volume":"134","author":"Z Wei","year":"2020","unstructured":"Wei Z, Meng X, El Fatimy R, Sun B, Mai D, Zhang J, et al. Environmental enrichment prevents A\u03b2 oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways. Neurobiol Dis. 2020;134:104617 https:\/\/doi.org\/10.1016\/j.nbd.2019.104617.","journal-title":"Neurobiol Dis"},{"key":"3095_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3233\/JAD-150432","volume":"48","author":"S Hu","year":"2015","unstructured":"Hu S, Wang H, Chen K, Cheng P, Gao S, Liu J, et al. MicroRNA-34c downregulation ameliorates amyloid-\u03b2-induced synaptic failure and memory deficits by targeting VAMP2. J Alzheimer\u2019s Dis: JAD. 2015;48:673\u201386. https:\/\/doi.org\/10.3233\/JAD-150432.","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"3095_CR52","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","volume":"13","author":"DJ Cha","year":"2019","unstructured":"Cha DJ, Mengel D, Mustapic M, Liu W, Selkoe DJ, Kapogiannis D, et al. miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients. Front Neurosci. 2019;13:1208 https:\/\/doi.org\/10.3389\/fnins.2019.01208.","journal-title":"Front Neurosci"},{"key":"3095_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03162-z","volume":"21","author":"C Song","year":"2024","unstructured":"Song C, Li S, Mai Y, Li L, Dai G, Zhou Y, et al. Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology. J Neuroinflammation. 2024;21:167 https:\/\/doi.org\/10.1186\/s12974-024-03162-z.","journal-title":"J Neuroinflammation"},{"key":"3095_CR54","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3892\/ijmm.2020.4602","volume":"46","author":"D Song","year":"2020","unstructured":"Song D, Li G, Hong Y, Zhang P, Zhu J, Yang L, et al. MiR\u2011199a decreases Neuritin expression involved in the development of Alzheimer\u2019s disease in APP\/PS1 mice. Int J Mol Med. 2020;46:384\u201396. https:\/\/doi.org\/10.3892\/ijmm.2020.4602.","journal-title":"Int J Mol Med"},{"key":"3095_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/DNND.S444567","volume":"14","author":"X Duan","year":"2024","unstructured":"Duan X, Zheng Q, Liang L, Zhou L. Serum exosomal miRNA-125b and miRNA-451a are potential diagnostic biomarker for Alzheimer\u2019s diseases. Degener Neurol Neuromuscul Dis. 2024;14:21\u201331. https:\/\/doi.org\/10.2147\/DNND.S444567.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"3095_CR56","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1074\/jbc.M112.381392","volume":"288","author":"C Cheng","year":"2013","unstructured":"Cheng C, Li W, Zhang Z, Yoshimura S, Hao Q, Zhang C, et al. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem. 2013;288:13748\u201361. https:\/\/doi.org\/10.1074\/jbc.M112.381392.","journal-title":"J Biol Chem"},{"key":"3095_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.b.30822","volume":"150B","author":"J Gauthier","year":"2009","unstructured":"Gauthier J, Spiegelman D, Piton A, Lafreni\u00e8re RG, Laurent S, St-Onge J, et al. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet Part B, Neuropsychiatr Genet. 2009;150B:421\u20134. https:\/\/doi.org\/10.1002\/ajmg.b.30822.","journal-title":"Am J Med Genet Part B, Neuropsychiatr Genet"},{"key":"3095_CR58","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ajhg.2012.03.017","volume":"90","author":"D Sato","year":"2012","unstructured":"Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, et al. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet. 2012;90:879\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2012.03.017.","journal-title":"Am J Hum Genet"},{"key":"3095_CR59","doi-asserted-by":"publisher","first-page":"e078629","DOI":"10.1002\/alz.078629","volume":"19","author":"MT Dauar","year":"2023","unstructured":"Dauar MT, Picard C, Labonte A, Poirier J. Evaluation of HIVEP3 polymorphic variants and gene expression in Alzheimer\u2019s disease. Alzheimer\u2019s and Dementia- Supplement: Basic Science and Pathogenesis. 2023;19:e078629 https:\/\/doi.org\/10.1002\/alz.078629.","journal-title":"Alzheimer\u2019s and Dementia- Supplement: Basic Science and Pathogenesis"},{"key":"3095_CR60","doi-asserted-by":"publisher","first-page":"202.e1","DOI":"10.1016\/j.neurobiolaging.2010.07.018","volume":"33","author":"DJ Lehmann","year":"2012","unstructured":"Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, K\u00f6lsch H, et al. Transferrin and HFE genes interact in Alzheimer\u2019s disease risk: The Epistasis Project. Neurobiol Aging. 2012;33:202.e1\u201313. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.07.018.","journal-title":"Neurobiol Aging"},{"key":"3095_CR61","doi-asserted-by":"publisher","first-page":"ENEURO.0045-20.","DOI":"10.1523\/ENEURO.0045-20.2020","volume":"7","author":"G Buscaglia","year":"2020","unstructured":"Buscaglia G, Northington KR, Moore JK, Bates EA. Reduced TUBA1A tubulin causes defects in trafficking and impaired adult motor behavior. eNeuro. 2020;7:ENEURO.0045-20.2020 https:\/\/doi.org\/10.1523\/ENEURO.0045-20.2020.","journal-title":"eNeuro"},{"key":"3095_CR62","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ccr3.358","volume":"3","author":"PN Adama van Scheltema","year":"2015","unstructured":"Adama van Scheltema PN, Zhang A, Ball LM, Steggerda SJ, van Wijk R, Fransen van de Putte DE, et al. Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report. Clin Case Rep. 2015;3:862\u20135. https:\/\/doi.org\/10.1002\/ccr3.358.","journal-title":"Clin Case Rep"},{"key":"3095_CR63","doi-asserted-by":"publisher","first-page":"1281748","DOI":"10.3389\/fnagi.2023.1281748","volume":"15","author":"EH Suh","year":"2023","unstructured":"Suh EH, Lee G, Jung SH, Wen Z, Bao J, Nho K, et al. An interpretable Alzheimer\u2019s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification. Front Aging Neurosci. 2023;15:1281748 https:\/\/doi.org\/10.3389\/fnagi.2023.1281748.","journal-title":"Front Aging Neurosci"},{"key":"3095_CR64","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","volume":"96","author":"NJ Allen","year":"2017","unstructured":"Allen NJ, Eroglu C. Cell biology of astrocyte-synapse interactions. Neuron. 2017;96:697\u2013708. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.056.","journal-title":"Neuron"},{"key":"3095_CR65","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/glia.24343","volume":"71","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shen X, Zhang Y, Zheng X, Cepeda C, Wang Y, et al. Interactions of glial cells with neuronal synapses, from astrocytes to microglia and oligodendrocyte lineage cells. Glia. 2023;71:1383\u2013401. https:\/\/doi.org\/10.1002\/glia.24343.","journal-title":"Glia."},{"key":"3095_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13064-018-0104-y","volume":"13","author":"I Farhy-Tselnicker","year":"2018","unstructured":"Farhy-Tselnicker I, Allen NJ. Astrocytes, neurons, synapses: a tripartite view on cortical circuit development. Neural Dev. 2018;13:7 https:\/\/doi.org\/10.1186\/s13064-018-0104-y.","journal-title":"Neural Dev"},{"key":"3095_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","volume":"22","author":"A Araque","year":"1999","unstructured":"Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: Glia, the unacknowledged partner. Trends Neurosci. 1999;22:208\u201315. 10.1016-2236(98)01349-6","journal-title":"Trends Neurosci"},{"key":"3095_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","volume":"13","author":"MM Halassa","year":"2007","unstructured":"Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med. 2007;13:54\u201363. https:\/\/doi.org\/10.1016\/j.molmed.2006.12.005.","journal-title":"Trends Mol Med"},{"key":"3095_CR69","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2009.05.001","volume":"32","author":"G Perea","year":"2009","unstructured":"Perea G, Navarrete M, Araque A. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci. 2009;32:421\u201331. https:\/\/doi.org\/10.1016\/j.tins.2009.05.001.","journal-title":"Trends Neurosci"},{"key":"3095_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","volume":"61","author":"DP Schafer","year":"2013","unstructured":"Schafer DP, Lehrman EK, Stevens B. The \u201cquad-partite\u201d synapse: microglia-synapse interactions in the developing and mature CNS. Glia. 2013;61:24\u201336. https:\/\/doi.org\/10.1002\/glia.22389.","journal-title":"Glia"},{"key":"3095_CR71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tins.2023.05.007","volume":"46","author":"J Buchanan","year":"2023","unstructured":"Buchanan J, da Costa NM, Cheadle L. Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling. Trends Neurosci. 2023;46:628\u201339. https:\/\/doi.org\/10.1016\/j.tins.2023.05.007.","journal-title":"Trends Neurosci"},{"key":"3095_CR72","doi-asserted-by":"publisher","first-page":"1386352","DOI":"10.3389\/fncel.2024.1386352","volume":"18","author":"JR Gronseth","year":"2024","unstructured":"Gronseth JR, Nelson HN, Johnson TL, Mallon TA, Martell MR, Pfaffenbach KA, et al. Synaptic vesicle release regulates pre-myelinating oligodendrocyte-axon interactions in a neuron subtype-specific manner. Front Cell Neurosci. 2024;18:1386352 https:\/\/doi.org\/10.3389\/fncel.2024.1386352.","journal-title":"Front Cell Neurosci"},{"key":"3095_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-023-00385-7","volume":"12","author":"P Zou","year":"2023","unstructured":"Zou P, Wu C, Liu TC, Duan R, Yang L. Oligodendrocyte progenitor cells in Alzheimer\u2019s disease: from physiology to pathology. Transl Neurodegener. 2023;12:52 https:\/\/doi.org\/10.1186\/s40035-023-00385-7.","journal-title":"Transl Neurodegener"},{"key":"3095_CR74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-024-00760-6","volume":"19","author":"SL Rossi","year":"2024","unstructured":"Rossi SL, Bovenkamp DE. Are oligodendrocytes the missing link in Alzheimer\u2019s disease and related dementia research? Mol Neurodegener. 2024;19:84 https:\/\/doi.org\/10.1186\/s13024-024-00760-6.","journal-title":"Mol Neurodegener"},{"key":"3095_CR75","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.nbd.2018.10.006","volume":"121","author":"KW Wu","year":"2019","unstructured":"Wu KW, Lv LL, Lei Y, Qian C, Sun FY. Endothelial cells promote excitatory synaptogenesis and improve ischemia-induced motor deficits in neonatal mice. Neurobiol Dis. 2019;121:230\u20139. https:\/\/doi.org\/10.1016\/j.nbd.2018.10.006.","journal-title":"Neurobiol Dis"},{"key":"3095_CR76","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fncel.2017.00290","volume":"11","author":"KW Wu","year":"2017","unstructured":"Wu KW, Mo JL, Kou ZW, Liu Q, Lv LL, Lei Y, et al. Neurovascular interaction promotes the morphological and functional maturation of cortical neurons. Front Cell Neurosci. 2017;11:290 https:\/\/doi.org\/10.3389\/fncel.2017.00290.","journal-title":"Front Cell Neurosci"},{"key":"3095_CR77","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s40478-019-0847-7","volume":"7","author":"R Hesse","year":"2019","unstructured":"Hesse R, Hurtado ML, Jackson RJ, Eaton SL, Herrmann AG, Colom-Cadena M, et al. Comparative profiling of the synaptic proteome from Alzheimer\u2019s disease patients with focus on the APOE genotype. Acta Neuropathol Commun. 2019;7:214 https:\/\/doi.org\/10.1186\/s40478-019-0847-7.","journal-title":"Acta Neuropathol Commun"},{"key":"3095_CR78","doi-asserted-by":"publisher","first-page":"147569","DOI":"10.1016\/j.brainres.2021.147569","volume":"1767","author":"Z Bian","year":"2021","unstructured":"Bian Z, Yamashita T, Shi X, Feng T, Yu H, Hu X, et al. Accelerated accumulation of fibrinogen peptide chains with A\u03b2 deposition in Alzheimer\u2019s disease (AD) mice and human AD brains. Brain Res. 2021;1767:147569 https:\/\/doi.org\/10.1016\/j.brainres.2021.147569.","journal-title":"Brain Res"},{"key":"3095_CR79","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrn.2018.13","volume":"19","author":"MA Petersen","year":"2018","unstructured":"Petersen MA, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat Rev Neurosci. 2018;19:283\u2013301. https:\/\/doi.org\/10.1038\/nrn.2018.13.","journal-title":"Nat Rev Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03095-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03095-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03095-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:52:03Z","timestamp":1760597523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03095-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03095-w","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"For AD and control human brain tissues, written informed consent for post-mortem brain donation was obtained from the families of donors through the NIH NeuroBioBank. Prior to their transfer to the TTUHSC El Paso, all samples were de-identified, thereby exempting them from the oversight of the Institutional Review Board (IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}